Cargando…

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)

This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) examined the performance of chlorthalidone (C) versus amlodipine (A) monotherapies. ANOVA was used to analyze the differences in systolic blood pressure (SBP) response between C and A. Logistic regression was used to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vakil, Deep, Zinonos, Stavros, Kostis, John B., Dobrzynski, Jeanne M., Cosgrove, Nora M., Moreyra, Abel E., Kostis, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678684/ https://www.ncbi.nlm.nih.gov/pubmed/34076333 http://dx.doi.org/10.1111/jch.14296

Ejemplares similares

US Initiative to Eliminate Racial and Ethnic Disparities in Health: The Impact on the Outcomes of ST‐Segment–Elevation Myocardial Infarction in New Jersey
por: Bhatia, Niharika, et al.
Publicado: (2023)

Use of advanced statistical techniques to predict all-cause mortality in the Systolic Blood Pressure Intervention Trial
por: Kostis, William J., et al.
Publicado: (2020)

Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial
por: Sung, Ki‐Chul, et al.
Publicado: (2022)

Association of orthostatic hypertension with mortality in the Systolic Hypertension in the Elderly Program
por: Kostis, William J., et al.
Publicado: (2019)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
por: Jo, Sang-Ho, et al.
Publicado: (2018)

Ambulatory blood pressure response to S‐amlodipine in Korean adult patients with uncontrolled essential hypertension: A prospective, observational study
por: Kim, Dong Kyun, et al.
Publicado: (2022)

Ischemic Stroke Rate Increases in Young Adults: Evidence for a Generational Effect?
por: Swerdel, Joel N., et al.
Publicado: (2016)

Statins and Erectile Dysfunction
por: Kostis, John B., et al.
Publicado: (2019)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
por: Still, Carolyn H, et al.
Publicado: (2018)

Pilot study of tocilizumab monotherapy for active chronic periaortitis
por: Wang, Anqi, et al.
Publicado: (2023)

Uses and opportunities for machine learning in hypertension research
por: Amaratunga, Dhammika, et al.
Publicado: (2020)

Prediction of stroke using an algorithm to estimate arterial stiffness
por: Kostis, John B., et al.
Publicado: (2021)

Azilsartan/chlorthalidone combination therapy for blood pressure control
por: Cheng, Judy WM
Publicado: (2013)

Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial
por: Lucca, Marcelo B., et al.
Publicado: (2023)

The Effect of Hurricane Sandy on Cardiovascular Events in New Jersey
por: Swerdel, Joel N., et al.
Publicado: (2014)

Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults
por: Chen, Liping, et al.
Publicado: (2020)

The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazide
por: Shin, Jinho, et al.
Publicado: (2019)

Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT)
por: Kern, Kyle C., et al.
Publicado: (2023)

Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
por: Ghazi, Lama, et al.
Publicado: (2022)

Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy
por: Neldam, Steen, et al.
Publicado: (2013)

Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT)
por: Agarwal, Rajiv
Publicado: (2017)

Tailoring Chlorthalidone Aqueous Solubility by Cocrystallization: Stability and Dissolution Behavior of a Novel Chlorthalidone-Caffeine Cocrystal
por: Rodríguez-Ruiz, Christian, et al.
Publicado: (2022)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Intensive Systolic Blood Pressure Treatment Remodels Brain Perivascular Spaces: A Secondary Analysis of SPRINT
por: Kern, Kyle C., et al.
Publicado: (2023)

Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT)
por: Glasser, Stephen P, et al.
Publicado: (2021)

Valsartan 160 mg/Amlodipine 5 mg Combination Therapy versus Amlodipine 10 mg in Hypertensive Patients with Inadequate Response to Amlodipine 5 mg Monotherapy
por: Sung, Jidong, et al.
Publicado: (2016)

PSUN274 Chlorthalidone-Induced Diabetic Ketoacidosis.
por: Zafar, Rafia, et al.
Publicado: (2022)

Thiazide diuretics are back in CKD: the case of chlorthalidone
por: Minutolo, Roberto, et al.
Publicado: (2022)

Radical Prostatectomy and Anatomical Controversies: The Urethral Sphincter and the Elusive Continence Mechanisms
por: Gyftopoulos, Kostis
Publicado: (2023)

Effects of Aliskiren Monotherapy versus Amlodipine Monotherapy in Hypertensive Patients with Obesity or Type 2 Diabetes Mellitus
por: Seki, Yasufumi, et al.
Publicado: (2023)

Blood Pressure Effects of High-Dose Amlodipine-Benazepril Combination in Black and White Hypertensive Patients Not Controlled on Monotherapy
por: Chrysant, Steven G.
Publicado: (2012)

Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT
por: Ghazi, Lama, et al.
Publicado: (2019)

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017)

Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Zang, Jiabin, et al.
Publicado: (2021)

Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Pareek, Manan, et al.
Publicado: (2021)

The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Still, Carolyn H, et al.
Publicado: (2018)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
por: Ihm, Sang-Hyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u247s7meisltv5t7prk2s1if5u